Skip to main content
. Author manuscript; available in PMC: 2017 Jul 27.
Published in final edited form as: Clin Trials. 2012 Apr 30;9(3):303–313. doi: 10.1177/1740774512443593

Table 1.

50–50 weighting scheme details: pseudodata represent one cohort (three patients), in a 3/30 cohort size/total sample size scenario

Number of pseudodata points Weight per pseudodata point Observed patients Weight per patient Sum of weights Percentage of weights from pseudodata Percentage of weights from observed patients
400 0.0075 3 1 6 50.00 50.00
400 0.0075 6 1 9 33.33 66.67
400 0.0075 9 1 12 25.00 75.00
400 0.0075 12 1 15 20.00 80.00
400 0.0075 15 1 18 16.67 83.33
400 0.0075 18 1 21 14.29 85.71
400 0.0075 21 1 24 12.50 87.50
400 0.0075 24 1 27 11.11 88.89
400 0.0075 27 1 30 10.00 90.00
400 0.0075 30 1 33 9.09 90.91